KADCYLA, as a single agent, is indicated for the treatment of patients with HER2-positive, metastatic breast cancer who previously received trastuzumab and a taxane, separately or in combination. Active ingredients in KADCYLA are: ado-trastuzumab emtansine. Inactive ingredients in KADCYLA are:citric acid monohydrate, lysine hydrochloride, polysorbate 80, trehalose dehydrate, sodium hydroxide and water for injection. KADCYLA (ado-trastuzumab emtansine) should be administered under the supervision of a qualified physician experienced in the uses of cancer chemotherapeutic agents.

Brand: KADCYLA is manufactured by Genentech, Inc. KADCYLA is available as Lyophilized powder in single-use vials containing 100 mg per vial or 160 mg per vial.

What is KADCYLA used for?

KADCYLA is a HER2-targeted antibody and microtubule inhibitor conjugate indicated, as a single agent, for the treatment of patients with HER2-positive, metastatic breast cancer who previously received trastuzumab and a taxane, separately or in combination. Patients should have either: 1. Received prior therapy for metastatic disease, or 2. Developed disease recurrence during or within six months of completing adjuvant therapy.

Please contact +91 9811747774 for KADCYLA (ado-trastuzumab emtansine) for injection cost in India

Where can I buy KADCYLA?

Indian Pharma Network helps patients, doctors and hospitals as a facilitator to import prescription medicine. Brand: KADCYLA. Generic: ado-trastuzumab emtansine on prescription and Import License in Patient's Name only.

Brand: KADCYLA is manufactured by Genentech, Inc.

KADCYLA can be made available Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune and other cities in India. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable

KADCYLA (ado-trastuzumab emtansine) for injection

Brand Name: KADCYLA.
Generic Name: ado-trastuzumab emtansine.

Get In Touch